Ignite Creation Date:
2025-12-25 @ 2:25 AM
Ignite Modification Date:
2025-12-27 @ 9:48 AM
Study NCT ID:
NCT00755534
Status:
TERMINATED
Last Update Posted:
2013-02-13
First Post:
2008-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC
Sponsor:
Hellenic Oncology Research Group